[1] Sarker A,Ginn R,Nikfarjam A,et al.Utilizing social media data for pharmacovigilance:A review[J].J Biomed Inform,2015,54:202-212. [2] Law of the PRC Governing the Management of Pharmaceutical Products[EB/OL].(2019-08-26)[2020-11-05].http://www.gov.cn/xinwen/2019-08/26/content_5424780.htm. [3] Wu JR,Zhang B.Discussion of traditional chinese medicine pharmacovigilance[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2009,18(5):312-315. [4] Zhang B,Lin ZJ,Zhang XM,et al.Pharmacovigilance of chinese medicine:mining and practice[J].Chinese Journal of Pharmacoe-pidemiology(药物流行病学杂志),2016,25(7):405-408. [5] NMPA Implementation opinions of the state food and drug administration on promoting the inheritance and innovation of traditional chinese medicine[EB/OL].(2020-12-25)[2021-01-05].https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201225163906151.html?type=pc&m=&from=timeline&isappinstalled=0&GXMEUwefOdZn=1608980146597. [6] Gao Y,An H,Xu WH,et al.Discussion on pharmacovigilance of traditional chinese medicine[J].Journal of Basic Chinese Medicine(中国中医基础医学杂志),2019,25(2):233-234. [7] NMPA The State Drug Administration.Pharmacovigilance quality management standard (Exposure Draft)[EB/OL].(2020-12-03)[2021-01-05].https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20201203164737146.html?type=pc&m=&GXMEUwefOdZn=1608987716806. [8] Zhang B.Pharmacovigilance of Chinese medicine (中药药物警戒)[M].Beijing:People's Medical Publishing House,2015:3-4. [9] Wang Y,Zhang B,Lin ZJ,et al.Chinese materia medica for suppressing hyperactive liver and calming endogenous wind:Safety analysis and pharmacovigilance considerations[J].China Journal of Traditional Chinese Medicine and 0harmacy(中华中医药杂志),2016,31(11):4643-4648. [10] Bai YF,Lin ZJ,Zhang B,et al.Chinese materia medica for rheum-atism:Safety analysis and pharmacovigilance considerations[J].China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志),2016,31(10):4117-4123. [11] Zhao W,Yang W,Gong Y,et al.Analysis of rational use of oral Chinese patent medicines with toxic herbal pieces as main drugs[J].Beijing Jour-nal of Traditional Chinese Medicine(北京中医药),2020,39(3):290-294. [12] Han L,Sun ZY,Yang W,et al.Safety evaluation and supervision of traditional chinese medicine[J].Chinese Journal of Pharmacology and toxicology(中国药理学与毒理学杂志),2020(11):801-810. [13] Mao QY,Lin ZJ,Wang Y,et al.Early warning of risks of sennae folium to constipation patients with breast cancer by bioinfo-rmatics[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2021,18(1):30-37. [14] Zhang D,Dong YZ,Lv JT,et al.Prediction of toxicity mechanism of kunming shanhaitang based on network pharmacology and with molecular docking[J].Journal of Beijing University of Traditional Chinese Medicine(北京中医药大学学报),2019,42(12):1006-1015. [15] Wang YG,Jin R,Kong XW,et al.Safety grade of application of traditional chinese medicines during pregnancy[J].Journal of Chinese Materia Medica(中国中药杂志),2016,41(1):150-153. [16] Zhao YP,Gao R,Lu F,et al.Thoughts on the construction of risk assessment system for the benefits of post-marketed traditional Chinese medicine[J].Beijing Journal of Traditional Chinese Medicine(北京中医药),2013,32(11):803-806. [17] Dang HX,Zhang L,Liu J,et al.Introduction and analysis of FDA's benefit-risk drug value assessment framework[J].Drug Evaluation Research(药物评价研究),2020,43(4):665-669. [18] Jin R,Wang YG,Zhang B.Establishment and verification of risk asses-sment scale for clinical safety medication of aconitine[J].China Journal of Chinese Materia Medica(中国中药杂志),2018,43(2):222-226. [19] Zhang XM,Li F,Zhang B,et al.Data-mining characteristics of adverse drug reactions and pharmacovigilance of chinese patent drugs including aconitum herbs[J].China Journal of Chinese Materia Medica(中国中药杂志),2018,43(2):216-221. [20] Zhang XM,Lin ZJ,Zhang B,et al.Traditional prescription rules of aconitum herbs in treatment of bi syndrome[J].China Journal of Chinese Materia Medica(中国中药杂志),2018,43(2):211-215. [21] Li LZ,Chai YF,Xue CM,et al.Effects of fuzi rougui and xianmao on immune function and energy metabolism of rats in different state[J/OL].Chinese 22 Archives of Traditional Chinese Medicine (中华中医药学刊).(2020-11-05)[2021-02-14].http://kns.cnki.net/kcms/detail/21.1546.R.20201104.1844.026.html. [22] Zhang D,Zhang XM,Dong YZ,et al.A network meta-analysis of aconitum species chinese patent medicines for patients with arthromyodynia[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2020,29(3):149-157. [23] Tian ZP,Zhang B,Zhang XM,et al.Application of aconitum medicines in puji fang for children[J].Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志),2019,25(21):176-181. [24] Wang Y,Lin ZJ,Jiang ZX,et al.Study of early warning of aconitum herbs in breast cancer therapy by bibliometric and bioinformatics[J/OL].Chinese Journal of Pharmacovigilance (中国药物警戒).(2020-12-28)[2021-02-14].http://kns.cnki.net/kcms/detail/11.5219.R.20201228.1325.006.html. [25] Cui YY,Wu JR,Zhang D,et al.Study on the epidemiological characteristics of adverse reaction caused by heat-clearing injection based on data mining[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2017,26(10):675-682. [26] Cui YY,Liu S,Wu JR,et al.Studies on the epidemiological char-acteristics of adverse reaction caused by shuanghuanglian injection bas-ed on bayesian network and decision tree algorithm[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2017,26(1):19-26. [27] Lv JT,Zhang B,Lin ZJ,et al.Domestic research progress on the combination of chinese and western medicine based on literature metrology and knowledge graph[J].Chinese Journal of Hospital Pharmacy(中国医院药学杂志),2020,40(21):2269-2275. [28] Qu CC,Zhang B,Lin ZJ,et al.Pharmacovigilance in materia medica works of qing dynasty[J].Journal of Chinese Materia Medica(中国中药杂志),2019,44(21):4751-4755. [29] Shi L,Liu X,Zhang B.Study on use of drug toxicity in pharmacovigi-lance thought of the compendium of materia medical[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(7):399-403. [30] Li F,Dong YZ,Zhang D,et al.Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering chinese herbs:a network pharmacology study and biology experiments[J].PLos One,2019,14(5):e0216948. [31] Jiang H,Zhang XM,Zhang B,et al.Benefit and risk of tripterygium glycosides tablets in treatment of rheumatoid arthritis based on multi-criteria decision-making analysis[J].Journal of Chinese Materia Medica(中国中药杂志),2020,45(4):798-808. [32] Tian ZP,Zhang B,Li F,et al.Investigation of clinical medication monitoring in 820 grassroots medical institutions[J].China Pharm- acist(中国药师),2019,22(3):457-461. [33] Li A,Zhang B.Survey and consideration on safety status of traditional chinese medicine application in 685 primary healthcare workers[J].Chin-ese Journal of Pharmacovigilance(中国药物警戒),2018,15(12):721-727. [34] Wang Y,Lin ZJ,Dong YZ,et al.Investigation of pharmaceutical services for traditional chinese medication precautions in medical institutions[J].China Pharmacist(中国药师),2018,21(12):2133-2139. |